|
TAF12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.845050E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.862300E-02 |
| Normal-vs-Stage2 |
4.793800E-01 |
| Normal-vs-Stage3 |
8.662000E-01 |
| Normal-vs-Stage4 |
4.849000E-01 |
| Stage1-vs-Stage2 |
2.759900E-02 |
| Stage1-vs-Stage3 |
2.971700E-02 |
| Stage1-vs-Stage4 |
4.375800E-01 |
| Stage2-vs-Stage3 |
5.557000E-01 |
| Stage2-vs-Stage4 |
2.491600E-01 |
| Stage3-vs-Stage4 |
4.188800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.866840E-01 |
| Normal-vs-AfricanAmerican |
7.348400E-01 |
| Normal-vs-Asian |
5.886500E-02 |
| Caucasian-vs-AfricanAmerican |
3.337600E-01 |
| Caucasian-vs-Asian |
3.429400E-01 |
| AfricanAmerican-vs-Asian |
1.035380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.100400E-01 |
| Normal-vs-Female |
1.700840E-01 |
| Male-vs-Female |
7.244600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.259500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.829000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.619800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.129600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.576400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.409720E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.473400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.404600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.720200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.309600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.436600E-01 |
| Classical-VS-Follicular |
6.935400E-03 |
| Classical-VS-Other |
6.757800E-01 |
| Classical-VS-Normal |
2.415800E-02 |
| Tall-VS-Follicular |
2.308600E-01 |
| Tall-VS-Other |
6.007400E-01 |
| Tall-VS-Normal |
4.328400E-01 |
| Follicular-VS-Other |
2.369600E-01 |
| Follicular-VS-Normal |
4.609200E-01 |
| Other-VS-Normal |
4.215600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.802200E-01 |
| Normal-vs-N1 |
7.525800E-01 |
| N0-vs-N1 |
9.841200E-01 |
|
|
